COLGATE-PALMOLIVE ($CL) posted quarterly earnings results for Q1 2026 on Friday, May 1st. The company reported earnings of $0.97 per share, missing estimates of $0.97 by $0.00. The company also reported revenue of $5,324,000,000, missing estimates of $5,371,895,814 by $-47,895,814.
You can see Quiver Quantitative's $CL stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
COLGATE-PALMOLIVE Insider Trading Activity
COLGATE-PALMOLIVE insiders have traded $CL stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CL stock by insiders over the last 6 months:
- STANLEY J III SUTULA (Chief Financial Officer) sold 97,843 shares for an estimated $9,223,287
- PANAGIOTIS TSOURAPAS (COO, Eur., APac, Afr Eur, Skin) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $4,778,436.
- NOEL R. WALLACE (Chairman, President & CEO) sold 45,568 shares for an estimated $4,279,495
- JENNIFER DANIELS (CLO and Secretary) sold 22,000 shares for an estimated $2,075,398
- JOHN HAZLIN (Chief Growth Officer) sold 20,989 shares for an estimated $1,978,211
- SALLY MASSEY (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 17,088 shares for an estimated $1,606,348.
- GREGORY MALCOLM (EVP and Controller) sold 12,747 shares for an estimated $1,209,821
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
COLGATE-PALMOLIVE Hedge Fund Activity
We have seen 785 institutional investors add shares of COLGATE-PALMOLIVE stock to their portfolio, and 878 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 18,376,766 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,452,132,049
- CITADEL ADVISORS LLC added 5,930,376 shares (+458.3%) to their portfolio in Q4 2025, for an estimated $468,618,311
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 4,598,789 shares (+8040.1%) to their portfolio in Q4 2025, for an estimated $363,396,306
- FMR LLC added 4,459,963 shares (+121.8%) to their portfolio in Q4 2025, for an estimated $352,426,276
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 4,282,241 shares (-80.7%) from their portfolio in Q4 2025, for an estimated $338,382,683
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,987,266 shares (-89.4%) from their portfolio in Q4 2025, for an estimated $315,073,759
- GQG PARTNERS LLC removed 3,969,183 shares (-34.9%) from their portfolio in Q4 2025, for an estimated $313,644,840
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
COLGATE-PALMOLIVE Analyst Ratings
Wall Street analysts have issued reports on $CL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 12/18/2025
- RBC Capital issued a "Outperform" rating on 12/09/2025
- Evercore ISI Group issued a "Outperform" rating on 11/03/2025
- Morgan Stanley issued a "Overweight" rating on 11/03/2025
- Citigroup issued a "Buy" rating on 11/03/2025
- UBS issued a "Buy" rating on 11/03/2025
To track analyst ratings and price targets for COLGATE-PALMOLIVE, check out Quiver Quantitative's $CL forecast page.
COLGATE-PALMOLIVE Price Targets
Multiple analysts have issued price targets for $CL recently. We have seen 14 analysts offer price targets for $CL in the last 6 months, with a median target of $95.0.
Here are some recent targets:
- Dara Mohsenian from Morgan Stanley set a target price of $95.0 on 04/23/2026
- Edward Lewis from Rothschild & Co set a target price of $100.0 on 04/21/2026
- Andrea Teixeira from JP Morgan set a target price of $95.0 on 04/17/2026
- Lauren Lieberman from Barclays set a target price of $79.0 on 04/14/2026
- Bryan Spillane from B of A Securities set a target price of $102.0 on 04/10/2026
- Michael Lavery from Piper Sandler set a target price of $92.0 on 04/08/2026
- Chris Carey from Wells Fargo set a target price of $92.0 on 04/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
